Potassium Channel Activators Cromakalim and Celikalim (WAY-120,491) Fail to Decrease Myocardial Infarct Size in the Anesthetized Canine

Jan M. Kitzen,John D. McCallum,Charlotte Harvey,Mary Ellen Morin,George Oshiro,Thomas J. Colatsky

Potassium Channel Activators Cromakalim and Celikalim (WAY-120,491) Fail to Decrease Myocardial Infarct Size in the Anesthetized Canine

1992

Jan M. Kitzen
John D. McCallum
Charlotte Harvey
Mary Ellen Morin
George Oshiro
Thomas J. Colatsky

The cardioprotective effects of the K channel activator drugs celikalim (WAY-120,491) and cromakalim were studied in a canine model of myocardial infarction consisting of 90 min of ischemia and 5 h of

Keywords:

Fissipedia
Rate pressure product
Ischemia
Potassium channel
Cromakalim
Activator (genetics)
Calcium channel blocker
Chemistry
Cardiology
Carnivora
Internal medicine
Myocardial infarction
Agonist
Hemodynamics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations